Although 90% of CF patients have an in-frame deletion that results in the mislocalization of the CFTR gene product, a small fraction of CF patients (~5%) have a missense mutation G551D-CFTR that has correct CFTR localization but reduced chloride channel activity (Van Goor et al., 2011). Here, CFTR is linked to cystic fibrosis.